| Wall Street Journal. Europe 1999 Robert Langreth |
| Title | Subject | Authors |
|---|
| AHP ready to close Fen-Phen diet-drug chapter.(Abstract) | Business, international | Robert Langreth, Laura Johannes, Richard B. Schmitt |
| American Home Products to cut staff.(Abstract) | Business, international | Robert Langreth |
| American Home shares sink on verdict.(Abstract) | Business, international | Robert Langreth |
| J&J agrees to stock swap for Centocor.(Abstract) | Business, international | Steven Lipin, Robert Langreth |
| Merck plans to buy Sibia for 81.4 million euros.(Abstract) | Business, international | Robert Langreth |
| Merck's profit jumps 12% on 24% sales increase.(Abstract) | Business, international | Robert Langreth |
| Pfizer considers unconditional bid.(for Warner-Lambert)(Statistical Data Included) | Business, international | Gardiner Harris, Robert Langreth |
| Pfizer's shares sag on earnings outlook.(Abstract) | Business, international | Robert Langreth |
| Potent brew: blending of AHP and Warner-Lambert signals deals ahead; European drug companies are seen following path of $70 billion transaction; stocking empty cupboards.(American Home Products, includes related article)(Statistical Data Included) | Business, international | Gardiner Harris, Nikhil Deogun, Steven Lipin, Robert Langreth, Michael Waldholz, Elyse Tanouye |
| Shire Pharmaceuticals will buy Roberts, creating new force in specialty drugs.(Abstract) | Business, international | Robert Langreth |
| Speaking now: Pfizer tries to snatch Warner-Lambert from rival AHP; record $82.4 billion bid is aimed at a cash cow and a research bull; letters fall on deaf ears.(American Home Products)(Statistical Data Included) | Business, international | Gardiner Harris, Steven Lipin, Robert Langreth, Ron Winslow |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
